The Administrative Core of the Duke Autoimmunity Center of Excellence (ACE) will provide leadership and support for the two basic research projects, the Pilot Research Project (if approved), the 5 ongoing clinical trials, and any new clinical trials approved by ACE Steering Committee. Its overarching goal will be to promote the objectives of this integrated basic and clinical research program, ensure the quality and progress of the individual funded projects, foster interactions among basic and clinical scientists, and facilitate the appropriate dissemination of research findings. The core will be under the direction of Dr. E. William St.Clair (Principal Investigator) who will also serve as the Clinical Research Representative. He will be responsible for overseeing all budgetary matters of the Duke ACE, organizing monthly meetings of the Executive Committee, arranging for the twice yearly ACE research meetings, and coordinating the preparation of non-competitive renewal applications. Dr. Tedder will serve as the Associate Director and Basic Research Representative of the Administrative Core and work closely with Dr. St.Clair in managing the ACE research enterprise, ensuring program relevance, and facilitating interactions between the basic and clinical scientists. Tammy Caudil (Department of Immunology) and Patty Might Davis (Division of Rheumatology and Immunology) will provide administrative support for the core. Together, they will adminstrate the fmaces, coordinate meetings, interface with NIAID staff and the institution responsible for the management of the ACE Discretionary Fund. The core will also utilize an Executive Committee to ensure effective management and integration of the projects, as well as coordinate an annual review of the resarch activities by the Duke ACE Advisory Board. Drs. St.Clair and Tedder will be joined on the Executive committee by Drs. Garnett Kelsoe, Russell Hall, and David Pisetsky. The Core will also support educational activities to enhance the visibility of the Center within Duke and provide a forum for communicating and exchanging research ideas. The Administrative Core will nurture a vibrant, interactive program of clinical and basic research that will advance our understanding about the role of B cells in autoimmune disease.

Public Health Relevance

The Administrative Core of the will support the basic and clinical research activities of the Duke Autoimmunity Center of Excellence and be led by Dr. E. William St.Clair (Director, Clinical Research Representative) and Dr. Thomas F. Tedder (Associate Director, Basic Research Representative). It will oversee all budgetary aspects of the Duke ACE and ensure the quality and progress of the projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI056363-10
Application #
8466198
Study Section
Special Emphasis Panel (ZAI1-QV-I)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
10
Fiscal Year
2013
Total Cost
$121,206
Indirect Cost
$32,091
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Look, Michael; Saltzman, W Mark; Craft, Joe et al. (2014) The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus. Biomaterials 35:1089-95
Spencer, Diane M; Gauley, Julie; Pisetsky, David S (2014) The properties of microparticles from RAW 264.7 macrophage cells undergoing in vitro activation or apoptosis. Innate Immun 20:239-48
Pop, Laurentiu M; Barman, Stephen; Shao, Chunli et al. (2014) A reevaluation of CD22 expression in human lung cancer. Cancer Res 74:263-71
Ullal, Anirudh J; Marion, Tony N; Pisetsky, David S (2014) The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells. Clin Immunol 154:178-87
Candando, Kathleen M; Lykken, Jacquelyn M; Tedder, Thomas F (2014) B10 cell regulation of health and disease. Immunol Rev 259:259-72
Lykken, Jacquelyn M; DiLillo, David J; Weimer, Eric T et al. (2014) Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice. J Immunol 193:746-56
Poe, Jonathan C; Kountikov, Evgueni I; Lykken, Jacquelyn M et al. (2014) EndoU is a novel regulator of AICD during peripheral B cell selection. J Exp Med 211:57-69
Luo, Wei; Mayeux, Jessica; Gutierrez, Toni et al. (2014) A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol 193:909-20
Hershberg, Uri; Meng, Wenzhao; Zhang, Bochao et al. (2014) Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome. Arthritis Res Ther 16:R51
Wang, Xiao; Stearns, Nancy A; Li, Xingfu et al. (2014) The effect of polyamines on the binding of anti-DNA antibodies from patients with SLE and normal human subjects. Clin Immunol 153:94-103

Showing the most recent 10 out of 114 publications